Skip to content
Companies

Pluri

Placenta-derived cell therapies

Raised to date

Not disclosed

No Form D filings on record

Investors
1

About

Pluri Inc. is a forward-thinking biotechnology company focused on developing innovative cell-based products and technologies. By addressing critical challenges in the realms of medicine, food production, and environmental sustainability, Pluri Inc. aims to revolutionize the landscape of regenerative medicine and sustainable agriculture.

Pluri stands out through its commitment to sustainability and its versatile application of cell-based technologies across diverse industries.

Product

Cell Therapies

Regenerative Medicine

Pluri Inc. develops innovative placenta-derived cell therapies designed to treat a variety of conditions including muscle injuries, osteoarthritis, and hematological disorders. These therapies leverage advanced biological technologies to provide effective regenerative solutions.

  • Placenta-derived cells for enhanced therapeutic efficacy
  • Targeting multiple clinical conditions
  • Application in regenerative medicine

Built for

Biotechnology and pharmaceutical companies, food companies, agricultural companies, researchers, and clinicians.